Trasylol Re-Examination To Follow After Bayer Halts Enrollment In BART Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Enrollment in the blood conservation study was stopped due to an increase in mortality in patients receiving aprotinin injection.